Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
British Journal of Cancer
|
January 26, 2000
CD3 directed bispecific antibodies induce increased lymphocyte-endothelial cell interactions in vitro
G Molema, J W Tervaert, B J Kroesen, et al.
Neuropathology and Applied Neurobiology
|
January 28, 2010
Review: on TRAIL for malignant glioma therapy?
J M A Kuijlen, E Bremer, J J A Mooij, et al.
International Journal of Cancer
|
April 16, 1998
Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas
W Helfrich, B J Kroesen, R C Roovers, et al.
Leukemia
|
November 24, 2006
The histone deacetylase inhibitor valproic acid potently augments gemtuzumab ozogamicin-induced apoptosis in acute myeloid leukemic cells
B ten Cate, D F Samplonius, T Bijma, et al.
Toxicology and Applied Pharmacology
|
March 4, 2015
Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters DNA methyltransferase (dnmt) expression in zebrafish (Danio rerio)
Neelakanteswar Aluru, Elaine Kuo, Lily W Helfrich, et al.
Current Pharmaceutical Design
|
November 11, 2008
Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals
H J K Ananias, I J de Jong, R A Dierckx, et al.
Leukemia
|
March 6, 2009
A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability
B ten Cate, E Bremer, M de Bruyn, et al.
British Journal of Cancer
|
January 1, 1997
A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood
W Helfrich, R ten Poele, G J Meersma, et al.
Chemical Communications (Cambridge, England)
|
August 22, 2019
A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery
F Reeßing, M C A Stuart, D F Samplonius, et al.
International Journal of Cancer
|
June 9, 1995
Reduction of EGP-2-positive pulmonary metastases by bispecific-antibody-redirected T cells in an immunocompetent rat model
B J Kroesen, W Helfrich, A Bakker, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
British Journal of Cancer
|
January 26, 2000
CD3 directed bispecific antibodies induce increased lymphocyte-endothelial cell interactions in vitro
G Molema, J W Tervaert, B J Kroesen, et al.
Neuropathology and Applied Neurobiology
|
January 28, 2010
Review: on TRAIL for malignant glioma therapy?
J M A Kuijlen, E Bremer, J J A Mooij, et al.
International Journal of Cancer
|
April 16, 1998
Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas
W Helfrich, B J Kroesen, R C Roovers, et al.
Leukemia
|
November 24, 2006
The histone deacetylase inhibitor valproic acid potently augments gemtuzumab ozogamicin-induced apoptosis in acute myeloid leukemic cells
B ten Cate, D F Samplonius, T Bijma, et al.
Toxicology and Applied Pharmacology
|
March 4, 2015
Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters DNA methyltransferase (dnmt) expression in zebrafish (Danio rerio)
Neelakanteswar Aluru, Elaine Kuo, Lily W Helfrich, et al.
Current Pharmaceutical Design
|
November 11, 2008
Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals
H J K Ananias, I J de Jong, R A Dierckx, et al.
Leukemia
|
March 6, 2009
A novel AML-selective TRAIL fusion protein that is superior to Gemtuzumab Ozogamicin in terms of in vitro selectivity, activity and stability
B ten Cate, E Bremer, M de Bruyn, et al.
British Journal of Cancer
|
January 1, 1997
A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood
W Helfrich, R ten Poele, G J Meersma, et al.
Chemical Communications (Cambridge, England)
|
August 22, 2019
A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery
F Reeßing, M C A Stuart, D F Samplonius, et al.
International Journal of Cancer
|
June 9, 1995
Reduction of EGP-2-positive pulmonary metastases by bispecific-antibody-redirected T cells in an immunocompetent rat model
B J Kroesen, W Helfrich, A Bakker, et al.
Page
of 5